Online-Ressource | |
Verfasst von: | Görtz, Magdalena [VerfasserIn] |
Huber, Ann-Kathrin [VerfasserIn] | |
Linz, Tim [VerfasserIn] | |
Schwab, Constantin [VerfasserIn] | |
Stenzinger, Albrecht [VerfasserIn] | |
Goertz, Lukas [VerfasserIn] | |
Bonekamp, David [VerfasserIn] | |
Schlemmer, Heinz-Peter [VerfasserIn] | |
Hohenfellner, Markus [VerfasserIn] | |
Titel: | Detection rate of prostate cancer in repeat biopsy after an initial negative magnetic resonance imaging/ultrasound-guided biopsy |
Verf.angabe: | Magdalena Görtz, Ann-Kathrin Huber, Tim Linz, Constantin Schwab, Albrecht Stenzinger, Lukas Goertz, David Bonekamp, Heinz-Peter Schlemmer and Markus Hohenfellner |
E-Jahr: | 2023 |
Jahr: | 17 May 2023 |
Umfang: | 16 S. |
Illustrationen: | Illustrationen |
Fussnoten: | Gesehen am 30.11.2023 |
Titel Quelle: | Enthalten in: Diagnostics |
Ort Quelle: | Basel : MDPI, 2011 |
Jahr Quelle: | 2023 |
Band/Heft Quelle: | 13(2023), 10, Artikel-ID 1761, Seite 1-16 |
ISSN Quelle: | 2075-4418 |
Abstract: | A negative multiparametric magnetic resonance imaging (mpMRI)-guided prostate biopsy in patients with suspected prostate cancer (PC) results in clinical uncertainty, as the biopsy can be false negative. The clinical challenge is to determine the optimal follow-up and to select patients who will benefit from repeat biopsy. In this study, we evaluated the rate of significant PC (sPC, Gleason score ≥7) and PC detection in patients who received a follow-up mpMRI/ultrasound-guided biopsy for persistent PC suspicion after a negative mpMRI/ultrasound-guided biopsy. We identified 58 patients at our institution that underwent repeat targeted biopsy in case of PI-RADS lesions and systematic saturation biopsy between 2014 and 2022. At the initial biopsy, the median age was 59 years, and the median prostate specific antigen level was 6.7 ng/mL. Repeat biopsy after a median of 18 months detected sPC in 3/58 (5%) patients and Gleason score 6 PC in 11/58 (19%). Among 19 patients with a downgraded PI-RADS score at the follow-up mpMRI, none had sPC. In conclusion, men with an initial negative mpMRI/ultrasound-guided biopsy had a high likelihood of not harboring sPC at repeat biopsy (95%). Due to the small size of the study, further research is recommended. |
DOI: | doi:10.3390/diagnostics13101761 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt. kostenfrei: Volltext: https://doi.org/10.3390/diagnostics13101761 |
kostenfrei: Volltext: https://www.mdpi.com/2075-4418/13/10/1761 | |
DOI: https://doi.org/10.3390/diagnostics13101761 | |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | magnetic resonance imaging |
MRI/TRUS fusion biopsy | |
PI-RADS | |
prostate cancer | |
prostate-specific antigen | |
K10plus-PPN: | 1853912441 |
Verknüpfungen: | → Zeitschrift |